Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-15

Clinical Trial Update: A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults [Phase 3]

View source ↗

Summary

Phase 3 study of GW685698X for perennial allergic rhinitis in adolescents and adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GW685698X

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial | Phase 3 | Status: COMPLETED